Analyst Ratings for Lucira Health Inc. (LHDX)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/4/2021 | William Blair | Brian Weinstein | Downgrade | Market Perform (Outperform) |
N/A (N/A) |
6.26 (0.45) |
-92.81% | Details |
| 4/13/2021 | BofA Securities » Updated 11/15/2022 |
Derik de Bruin | Downgrade | Underperform (Buy) |
0.75 (3.00) |
10.91 (0.45) |
-95.88% | Details |
